Sartorius Stedim Biotech

Sartorius’ roots go all the way back to the 1870s when Florenz Sartorius founded "Feinmechanische Werkstatt F. Sartorius” in Goettingen, Germany. Although initially starting out as a company specialized in weighing and balance equipment, Sartorius has evolved over the last 150 years to become an important partner for the biopharmaceutical and life science industries.

The company has grown its products and services through acquisitions as well as organic growth and internal innovation. The Stedim acquisition about a decade ago brought single use bags and film technology to the company’s portfolio. Today, the company has a full suite of scalable products for upstream bioprocessing. Most recently, Sartorius expanded its downstream portfolio. For chromatography solutions in particular, with products acquired from Danaher, BIA Separations and most recently Novasep, Sartorius has solutions to assist with emerging modalities, such as mRNA, pDNA and AAV, as well as mAbs and traditional vaccines.

At the company’s annual general shareholders’ meeting in March 2022, the company said that group sales revenue in 2021 increased by almost 50 percent compared with 2020, with growth in the lab products & services division, as well as the bioprocess solutions division. The company is currently focusing on expanding its global footprint to better serve its customers, with the goal of doubling capacity for key product groups by 2025.